US Stock MarketDetailed Quotes

NRXP NRX Pharmaceuticals

Watchlist

3.4796
+0.3396+10.82%

Trading Apr 26 13:38 ET

36.49MMarket Cap-869P/E (TTM)

NRX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-77.09%4.6M

-51.22%8.9M

-39.02%14.97M

-58.94%16.51M

-27.35%20.05M

-53.07%18.25M

83.38%24.55M

--40.2M

-Cash and cash equivalents

-77.09%4.6M

-51.22%8.9M

-39.02%14.97M

-58.94%16.51M

-27.35%20.05M

-53.07%18.25M

83.38%24.55M

--40.2M

Receivables

-14.29%6K

-98.90%6K

-98.92%6K

--6K

--7K

--547K

--554K

----

-Other receivables

-14.29%6K

-98.90%6K

-98.92%6K

--6K

--7K

--547K

--554K

----

Prepaid assets

-60.18%2.28M

-30.37%4.18M

-34.18%4.81M

55.06%5.24M

12.23%5.73M

-5.45%6.01M

42.05%7.31M

--3.38M

Total current assets

-73.31%6.88M

-47.22%13.09M

-38.95%19.79M

-50.08%21.76M

-21.15%25.8M

-45.17%24.8M

74.89%32.41M

--43.58M

Non current assets

Other non current assets

1,952.38%431K

-8.70%21K

10.53%21K

41.18%24K

40.00%21K

44.46%23K

49.25%19K

--17K

Total non current assets

1,952.38%431K

-8.70%21K

10.53%21K

41.18%24K

40.00%21K

44.46%23K

49.25%19K

--17K

Total assets

-71.66%7.32M

-47.19%13.11M

-38.92%19.81M

-50.05%21.78M

-21.12%25.82M

-45.14%24.82M

74.87%32.43M

--43.6M

Liabilities

Current liabilities

Payables

123.12%4.63M

81.96%3.95M

-2.83%2.99M

-12.41%3.78M

-43.69%2.08M

-61.00%2.17M

-50.90%3.08M

--4.31M

-accounts payable

123.12%4.63M

67.48%3.63M

-28.36%2.21M

-12.41%3.78M

-43.69%2.08M

-61.00%2.17M

-50.90%3.08M

--4.31M

-Other payable

----

--314K

--786K

----

Current accrued expenses

-9.20%5.24M

-8.85%5.3M

73.14%6.9M

35.97%6.07M

102.85%5.77M

84.70%5.82M

50.93%3.98M

--4.47M

Current debt and capital lease obligation

18.93%9.16M

--10.07M

--12.69M

2,244.04%12.19M

1,387.07%7.7M

----

--520K

-Current debt

18.93%9.16M

--10.07M

--12.69M

2,244.04%12.19M

1,387.07%7.7M

----

--520K

Other current liabilities

-54.05%17K

-82.14%10K

89.47%36K

-99.04%25K

-99.24%37K

-99.79%56K

-99.93%19K

--2.61M

Current liabilities

22.22%19.05M

140.33%19.33M

219.40%22.62M

85.22%22.06M

30.71%15.59M

-77.84%8.04M

-80.04%7.08M

--11.91M

Non current liabilities

Long term debt and capital lease obligation

----

--2.82M

----

-Long term debt

----

--2.82M

----

Total non current liabilities

--0

--2.82M

--0

Total liabilities

3.48%19.05M

140.33%19.33M

219.40%22.62M

85.22%22.06M

54.38%18.41M

-77.84%8.04M

-80.32%7.08M

--11.91M

Shareholders'equity

Share capital

29.85%87K

27.94%87K

19.40%80K

4.48%70K

13.56%67K

24.06%68K

37.85%67K

--67K

-common stock

25.37%84K

23.53%84K

19.40%80K

4.48%70K

13.56%67K

24.06%68K

37.85%67K

--67K

-Preferred stock

--3K

--0

Retained earnings

-13.52%-253.15M

-16.95%-248.82M

-19.19%-242.75M

-18.99%-234.04M

-21.69%-223M

-39.56%-212.76M

-54.68%-203.67M

---196.69M

Paid-in capital

4.77%241.33M

5.69%242.53M

4.77%239.89M

2.31%233.58M

12.92%230.34M

42.21%229.47M

100.51%228.96M

--228.31M

Gains losses not affecting retained earnings

---3K

---22K

--106K

--0

----

Total stockholders'equity

-258.36%-11.73M

-137.05%-6.22M

-111.08%-2.81M

-100.90%-284K

-64.39%7.41M

87.14%16.78M

245.39%25.35M

--31.69M

Total equity

-258.36%-11.73M

-137.05%-6.22M

-111.08%-2.81M

-100.90%-284K

-64.39%7.41M

87.14%16.78M

245.39%25.35M

--31.69M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-77.09%4.6M	-77.09%4.6M	-51.22%8.9M	-39.02%14.97M	-58.94%16.51M	-27.35%20.05M	-27.35%20.05M	-53.07%18.25M	83.38%24.55M	--40.2M
-Cash and cash equivalents	-77.09%4.6M	-77.09%4.6M	-51.22%8.9M	-39.02%14.97M	-58.94%16.51M	-27.35%20.05M	-27.35%20.05M	-53.07%18.25M	83.38%24.55M	--40.2M
Receivables	-14.29%6K	-14.29%6K	-98.90%6K	-98.92%6K	--6K	--7K	--7K	--547K	--554K	----
-Other receivables	-14.29%6K	-14.29%6K	-98.90%6K	-98.92%6K	--6K	--7K	--7K	--547K	--554K	----
Prepaid assets	-60.18%2.28M	-60.18%2.28M	-30.37%4.18M	-34.18%4.81M	55.06%5.24M	12.23%5.73M	12.23%5.73M	-5.45%6.01M	42.05%7.31M	--3.38M
Total current assets	-73.31%6.88M	-73.31%6.88M	-47.22%13.09M	-38.95%19.79M	-50.08%21.76M	-21.15%25.8M	-21.15%25.8M	-45.17%24.8M	74.89%32.41M	--43.58M
Non current assets
Other non current assets	1,952.38%431K	1,952.38%431K	-8.70%21K	10.53%21K	41.18%24K	40.00%21K	40.00%21K	44.46%23K	49.25%19K	--17K
Total non current assets	1,952.38%431K	1,952.38%431K	-8.70%21K	10.53%21K	41.18%24K	40.00%21K	40.00%21K	44.46%23K	49.25%19K	--17K
Total assets	-71.66%7.32M	-71.66%7.32M	-47.19%13.11M	-38.92%19.81M	-50.05%21.78M	-21.12%25.82M	-21.12%25.82M	-45.14%24.82M	74.87%32.43M	--43.6M
Liabilities
Current liabilities
Payables	123.12%4.63M	123.12%4.63M	81.96%3.95M	-2.83%2.99M	-12.41%3.78M	-43.69%2.08M	-43.69%2.08M	-61.00%2.17M	-50.90%3.08M	--4.31M
-accounts payable	123.12%4.63M	123.12%4.63M	67.48%3.63M	-28.36%2.21M	-12.41%3.78M	-43.69%2.08M	-43.69%2.08M	-61.00%2.17M	-50.90%3.08M	--4.31M
-Other payable	----	----	--314K	--786K	----	----	----	----	----	----
Current accrued expenses	-9.20%5.24M	-9.20%5.24M	-8.85%5.3M	73.14%6.9M	35.97%6.07M	102.85%5.77M	102.85%5.77M	84.70%5.82M	50.93%3.98M	--4.47M
Current debt and capital lease obligation	18.93%9.16M	18.93%9.16M	--10.07M	--12.69M	2,244.04%12.19M	1,387.07%7.7M	1,387.07%7.7M	----	----	--520K
-Current debt	18.93%9.16M	18.93%9.16M	--10.07M	--12.69M	2,244.04%12.19M	1,387.07%7.7M	1,387.07%7.7M	----	----	--520K
Other current liabilities	-54.05%17K	-54.05%17K	-82.14%10K	89.47%36K	-99.04%25K	-99.24%37K	-99.24%37K	-99.79%56K	-99.93%19K	--2.61M
Current liabilities	22.22%19.05M	22.22%19.05M	140.33%19.33M	219.40%22.62M	85.22%22.06M	30.71%15.59M	30.71%15.59M	-77.84%8.04M	-80.04%7.08M	--11.91M
Non current liabilities
Long term debt and capital lease obligation	----	----	----	----	----	--2.82M	--2.82M	----	----	----
-Long term debt	----	----	----	----	----	--2.82M	--2.82M	----	----	----
Total non current liabilities	--0	--0	--0	--0	--0	--2.82M	--2.82M	--0	--0	--0
Total liabilities	3.48%19.05M	3.48%19.05M	140.33%19.33M	219.40%22.62M	85.22%22.06M	54.38%18.41M	54.38%18.41M	-77.84%8.04M	-80.32%7.08M	--11.91M
Shareholders'equity
Share capital	29.85%87K	29.85%87K	27.94%87K	19.40%80K	4.48%70K	13.56%67K	13.56%67K	24.06%68K	37.85%67K	--67K
-common stock	25.37%84K	25.37%84K	23.53%84K	19.40%80K	4.48%70K	13.56%67K	13.56%67K	24.06%68K	37.85%67K	--67K
-Preferred stock	--3K	--3K	--3K	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-13.52%-253.15M	-13.52%-253.15M	-16.95%-248.82M	-19.19%-242.75M	-18.99%-234.04M	-21.69%-223M	-21.69%-223M	-39.56%-212.76M	-54.68%-203.67M	---196.69M
Paid-in capital	4.77%241.33M	4.77%241.33M	5.69%242.53M	4.77%239.89M	2.31%233.58M	12.92%230.34M	12.92%230.34M	42.21%229.47M	100.51%228.96M	--228.31M
Gains losses not affecting retained earnings	---3K	---3K	---22K	---22K	--106K	--0	--0	----	----	----
Total stockholders'equity	-258.36%-11.73M	-258.36%-11.73M	-137.05%-6.22M	-111.08%-2.81M	-100.90%-284K	-64.39%7.41M	-64.39%7.41M	87.14%16.78M	245.39%25.35M	--31.69M
Total equity	-258.36%-11.73M	-258.36%-11.73M	-137.05%-6.22M	-111.08%-2.81M	-100.90%-284K	-64.39%7.41M	-64.39%7.41M	87.14%16.78M	245.39%25.35M	--31.69M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall